🧬 SinoBioData Academic Portal
Open AccessDOI: 10.3724/abbs.2025205Original Research

Effective resistance to UVB-induced skin damage through the encapsulation of chebulinic acid in mulberry-derived exosome-like nanoparticles

🇨🇳 Original Chinese Title: Effective resistance to UVB-induced skin damage through the encapsulation of chebulinic acid in mulberry-derived exosome-like nanoparticles

Weiwei Zhao¹,Ruobing Liu¹,Siqi Yang¹,Chaozhi Liu¹,Songlin Guo¹,Guihong Sun¹,Mingxiong Guo¹

Key Laboratory of Biodiversity and Environment on the Qinghai-Tibet Plateau, Ministry of Education, School of Ecology and Environment, Tibet University

Read Executive PreviewQuick FAQ
Effective resistance to UVB-induced skin damage through the encapsulation of chebulinic acid in mulberry-derived exosome-like nanoparticles
Graphical Abstract / Figure
Published In
Acta Biochimica et Biophysica Sinica
Published:2026Edition:Vol. 58, Issue 8 • pp. 1842-1854Citation:Weiwei Zhao et al. (2026), Acta Biochimica et Biophysica Sinica
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Acta Biochimica et Biophysica Sinica (生物化学与生物物理学报).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • Chebulinic acid (CA) from Terminalia chebula shows superior efficacy in promoting recovery from UVB-induced skin damage compared to other major monomers. • CA's anti-UVB mechanism involves regulation of IL-6 and IFN-β expression via activation of the MAPK pathway. • Mulberry exosome-like nanoparticles (MELNs) serve as an efficient transdermal delivery system, enhancing skin penetration and anti-UVB efficiency of CA. • The CA@MELNs platform offers a robust and accessible approach for mitigating UVB damage, combining natural phytochemicals with nanobiotechnology.
Sponsored Research Highlight

Abstract

Ultraviolet-B (UVB) radiation induces significant skin damage by penetrating into the dermal layer, leading to reactive oxygen species (ROS) generation and triggering cellular necrosis and apoptosis. Conventional sunscreens focus primarily on UVB blocking but are limited in their ability to repair dermal damage due to insufficient permeability. In this study, we discover that chebulinic acid (CA), one of the principal monomers in Terminalia chebula Retz., has superior efficacy in promoting recovery from UVB-induced skin damage compared with other major monomers. Mechanistically, CA’s anti-UVB function involves regulating the expression of IL-6 and IFN-β through activation of the MAPK pathway. To overcome the formidable barrier posed by the skin, we identify mulberry exosome-like nanoparticles (MELNs) as an efficient transdermal delivery system and develop CA@MELNs loaded with CA. Furthermore, we demonstrate that the dissociative CA within the CA@MELNs delivery system significantly enhances both transdermal penetration and anti-UVB efficiency in vitro and in vivo. Our findings suggest the substantial potential of CA as an effective ingredient and CA@MELNs as a robust and accessible platform for mitigating UVB damage.

1. Introduction

As the concentration of greenhouse gases continues to rise, the depletion of the Earth’s ozone layer has led to a gradual increase in the amount of solar ultraviolet (UV) radiation reaching the Earth’s surface. UV radiation, particularly within the UVB spectrum (280–320 nm), poses significant threats to cutaneous health through various mechanisms. Although UVB accounts for only 1%–10% of total terrestrial UV exposure, its high-energy photons cause direct DNA damage, resulting in carcinogenic effects on the skin through the formation of cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts. Simultaneously, UVB radiation generates reactive oxygen species (ROS), which induce oxidative stress, inflammation, and apoptosis [1–3]. Chronic UVB exposure disrupts epidermal homeostasis, accelerating photoaging through collagen degradation and promoting carcinogenesis [4,5]. Although conventional sunscreens utilize synthetic filters such as oxybenzone and avobenzone, increasing concerns regarding their endocrine-disrupting potential, photostability limitations, and inability to mitigate secondary oxidative damage necessitate the exploration of natural phytochemical alternatives with intrinsic antioxidant and UV-absorbing properties.

Numerous natural Chinese medicine products have been shown to have anti-UVB effects. Fruits of Terminalia chebula Retz. (T. chebula Retz.), revered as the “King of Tibetan Medicine”, has emerged as a compelling candidate for photoprotective phytochemical discovery. Phytochemical analyses revealed that T. chebula synthesizes hydrolyzable tannins such as chebulinic acid (CA), which is a polyphenolic compound that scavenges ROS and has anti-inflammatory and antiapoptotic activities [6–8]. ROS is highly correlated with skin damage caused by ultraviolet radiation [9–11], but the relationship between CA and UVB has not been reported to date. The therapeutic potential of CA is constrained by the formidable barrier of the skin [12]: its molecular weight (~956 Da) exceeds the 500 Da threshold for passive transdermal diffusion, whereas its polar groups impede lipid bilayer penetration.

To address the bioavailability challenge, transdermal delivery nanocarriers have been employed. Specifically, plant-derived exosome-like nanoparticles (PELNs), which are naturally evolved nanocarriers for intercellular biomolecule transport, have shown promise. PELNs possess several advantages: (1) their lipid bilayer structure (50–150 nm in diameter) facilitates fusion with epidermal membranes, thereby bypassing the size exclusion limit of the stratum corneum; (2) high deformability allows for intercellular penetration without compromising the integrity of the skin barrier; and (3) the presence of endogenous phospholipids enhances cargo solubility and biocompatibility while minimizing immunogenicity. Importantly, the lipophilic nature of PELNs facilitates the dermal delivery of hydrophobic phytochemicals, while their plant origin ensures superior biodegradability and cutaneous tolerability compared with synthetic nanocarriers [13–15].

This study pioneers the integration of the phytochemical legacy of Tibetan medicine with cutting-edge nanobiotechnology, establishing CA@MELNs as a biocompatible platform for advanced topical photoprotection. By elucidating the mechanistic interplay between CA-induced ROS scavenging and MELN delivery efficacy, we expand the translational potential of PELNs.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
Weiwei Zhao, Ruobing Liu, Siqi Yang, Chaozhi Liu, Songlin Guo, Guihong Sun, Mingxiong Guo (2026). Effective resistance to UVB-induced skin damage through the encapsulation of chebulinic acid in mulberry-derived exosome-like nanoparticles. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025205
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is the main finding of this study?

The study discovers that chebulinic acid (CA) from Terminalia chebula has superior efficacy in promoting recovery from UVB-induced skin damage, and when encapsulated in mulberry exosome-like nanoparticles (CA@MELNs), it enhances transdermal penetration and anti-UVB efficiency both in vitro and in vivo.

How does chebulinic acid protect against UVB damage?

Chebulinic acid regulates the expression of IL-6 and IFN-β through activation of the MAPK pathway, thereby mitigating UVB-induced skin damage.

Why are mulberry exosome-like nanoparticles used?

Mulberry exosome-like nanoparticles (MELNs) serve as an efficient transdermal delivery system, overcoming the skin barrier and enhancing the delivery of chebulinic acid to the dermis, thus improving its anti-UVB efficacy.

What are the potential applications of this research?

The CA@MELNs platform offers a robust and accessible approach for topical photoprotection, potentially leading to natural, biocompatible sunscreens or skin repair formulations that mitigate UVB damage.

What is the significance of using plant-derived nanoparticles?

Plant-derived exosome-like nanoparticles (PELNs) are biodegradable, biocompatible, and have low immunogenicity, making them superior to synthetic nanocarriers for transdermal delivery of phytochemicals.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF